Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013;8(2):e56956.
doi: 10.1371/journal.pone.0056956. Epub 2013 Feb 19.

Unbiased and mobile gait analysis detects motor impairment in Parkinson's disease

Affiliations

Unbiased and mobile gait analysis detects motor impairment in Parkinson's disease

Jochen Klucken et al. PLoS One. 2013.

Abstract

Motor impairments are the prerequisite for the diagnosis in Parkinson's disease (PD). The cardinal symptoms (bradykinesia, rigor, tremor, and postural instability) are used for disease staging and assessment of progression. They serve as primary outcome measures for clinical studies aiming at symptomatic and disease modifying interventions. One major caveat of clinical scores such as the Unified Parkinson Disease Rating Scale (UPDRS) or Hoehn&Yahr (H&Y) staging is its rater and time-of-assessment dependency. Thus, we aimed to objectively and automatically classify specific stages and motor signs in PD using a mobile, biosensor based Embedded Gait Analysis using Intelligent Technology (eGaIT). eGaIT consist of accelerometers and gyroscopes attached to shoes that record motion signals during standardized gait and leg function. From sensor signals 694 features were calculated and pattern recognition algorithms were applied to classify PD, H&Y stages, and motor signs correlating to the UPDRS-III motor score in a training cohort of 50 PD patients and 42 age matched controls. Classification results were confirmed in a second independent validation cohort (42 patients, 39 controls). eGaIT was able to successfully distinguish PD patients from controls with an overall classification rate of 81%. Classification accuracy increased with higher levels of motor impairment (91% for more severely affected patients) or more advanced stages of PD (91% for H&Y III patients compared to controls), supporting the PD-specific type of analysis by eGaIT. In addition, eGaIT was able to classify different H&Y stages, or different levels of motor impairment (UPDRS-III). In conclusion, eGaIT as an unbiased, mobile, and automated assessment tool is able to identify PD patients and characterize their motor impairment. It may serve as a complementary mean for the daily clinical workup and support therapeutic decisions throughout the course of the disease.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: This study was partly funded by a project grant of ASTRUM IT GmbH. Shoes were provided by adidas® AG. J. Barth and R. Steidl are employed by ASTRUM IT GmbH. eGaIT as developed and described in the present manuscript serves scientific interest in its present form. The automated gait analysis system as described is not a commercial product. Here, the authors present a “proof-of-principle” for the ability of sensor based gait analysis to be used as patients diagnostic and therapy monitoring tool. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Figures

Figure 1
Figure 1. Embedded gait analysis using intelligent technology (eGaIT) concept.
A: Shoe equipped with biosensors. B: Exemplary raw signal data from accelerometer with some automated computed features. C: Pattern recognition includes feature extraction from biosensor signals followed by selection, and classification of subgroups. Different pattern recognition algorithms were created: APD distinguishes between patients and controls, is generated in a training population and validated in an independent validation population. AH&Y and AUPDRS classify PD subgroups and include all samples.
Figure 2
Figure 2. Single feature changes of gait characteristics in PD.
Individual feature show significant differences between PD and controls (representative examples A, two-feature blots B), but groups overlap substantially (*: p≤0.001, T-test).

References

    1. Jankovic J (2008) Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 79: 368–376. - PubMed
    1. Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A (2009) Course in Parkinson disease subtypes: A 39-year clinicopathologic study. Neurology 73: 206–212. - PubMed
    1. Ellis T, Cavanaugh JT, Earhart GM, Ford MP, Foreman KB, et al. (2011) Which measures of physical function and motor impairment best predict quality of life in Parkinson's disease? Parkinsonism Relat Disord 17: 693–697. - PMC - PubMed
    1. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, et al. (2007) Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord 22: 41–47. - PubMed
    1. Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, et al. (2004) Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 19: 1020–1028. - PubMed

Publication types